SG
Sean Grant
Chief Financial Officer

Sean Grant insider trades: Vera Therapeutics (VERA) stock buys and sales

Chief Financial Officer, Vera Therapeutics Last trade Feb 23, 2026 13 Form 4 filings
$208K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
14
Open-market trades
since 2022
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Sean reports to the SEC

Open-market buys and sales

14 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 23, 2026VERA↓ Sell$208K
Apr 3, 2024VERA↓ Sell$4.0M
Apr 3, 2024VERA↓ Sell$513K
Apr 3, 2024VERA↓ Sell$111K
Apr 3, 2024VERA↓ Sell$49K
Apr 3, 2024VERA↓ Sell$34K
Apr 3, 2024VERA↓ Sell$15K
Apr 3, 2024VERA↓ Sell$13K
Jun 23, 2023VERA↑ Buy$83K
Jun 15, 2022VERA↑ Buy$38K
Jun 15, 2022VERA↑ Buy$13K
Jun 15, 2022VERA↑ Buy$12K
Jun 15, 2022VERA↑ Buy$5K
Feb 6, 2022VERA↑ Buy$100K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other VERA insiders

Open-market trades in the last 12 months

About Sean Grant's insider trades

Sean Grant is Chief Financial Officer at Vera Therapeutics (VERA). Since Feb 6, 2022, Sean has reported 6 open-market purchases worth $251K and 8 sales worth $4.9M on SEC Form 4. In the last 12 months: 1 sale ($208K).

Their filings also include grants and awards (7 filings), option exercises (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VERA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.